Feature Channels:

Pharmaceuticals

Add to Favorites Subscribe Share
fbshare-Pharmaceuticals

Showing results

110 of 3442
HSC-1489-NewsHeader-1200w.png

Article ID: 719401

Leukemia Drug Shows Promise for Treating a Childhood Brain Cancer

University of California San Diego Health

Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer.

Released:
20-Sep-2019 4:20 PM EDT
iu_logo.gif
  • Embargo expired:
    20-Sep-2019 5:00 AM EDT

Article ID: 719178

Open Medicare Data Helps Uncover Potential Hidden Costs of Health Care

Indiana University

IU scientists studying Medicare data have found an association between health care industry payments to medical providers for non-research expenses and what these providers charge for medical services.

Released:
18-Sep-2019 10:35 AM EDT

Law and Public Policy

mmc-logo.gif

Article ID: 719306

حصول Mayo Clinic على اعتماد إدارة الغذاء والدواء الأمريكية (FDA) لمنشأة تصوير متطور للكشف عن السرطان

Mayo Clinic

اعتمدت إدارة الغذاء والدواء الأمريكية استخدام منشأة الكمياء الإشعاعية للتصوير المقطعي بالإصدار البوزيتروني، والتي تُعرَف أيضًا باسم منشأة سيكلوترون، في Mayo Clinic بفلوريدا.

Released:
19-Sep-2019 3:05 PM EDT
OSU-WexMedCtr-HorizK-RGBHEX.jpg

Article ID: 719282

How to Taper Off Opioid Medications Safely

Ohio State University Wexner Medical Center

Whitney Luke, MD, a board certified pain medicine and addiction medicine specialist at The Ohio State University Wexner Medical Center, explains how to properly taper opioid medication.

Released:
19-Sep-2019 12:05 PM EDT
Newswise: Getting New Medical Treatments to Patients Can be Harder Than Landing on Mars

Article ID: 719188

Getting New Medical Treatments to Patients Can be Harder Than Landing on Mars

Georgia Institute of Technology

It takes about 10 years and $100 million to get a new medical device to market - $1 billion for a new drug. Most new solutions fail. The biggest foils are not the science or pre-clinical trials but the lack of finances, market miscalculation, bad business models, and regulatory snags. They can all be overcome.

Released:
18-Sep-2019 11:40 AM EDT
mmc-logo.gif

Article ID: 719190

Investigadores de Mayo demuestran reducción de carga de células senescentes en los humanos con fármacos senolíticos

Mayo Clinic

En un pequeño ensayo clínico sobre seguridad y factibilidad, los investigadores de Mayo Clinic por vez primera demostraron que es posible extraer del cuerpo a las células senescentes con los fármacos llamados “senolíticos”. El resultado se verificó no solamente con análisis de sangre, sino también con el cambio en la abundancia de células senescentes en la piel y el tejido graso. Los resultados se publican en la revista EBioMedicine.

Released:
18-Sep-2019 11:30 AM EDT
Newswise: Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer

Article ID: 719191

Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer

Roswell Park Comprehensive Cancer Center

In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients with some head/neck and lung cancers.

Released:
18-Sep-2019 11:05 AM EDT
Newswise: MicroRNA-based Therapy May be New Weapon to Combat Cancer

Article ID: 719166

MicroRNA-based Therapy May be New Weapon to Combat Cancer

Stony Brook University

A technology that manipulates microRNAs (miRNAs) developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

Released:
18-Sep-2019 9:05 AM EDT

Feature

Channels:

Cancer, Pharmaceuticals,

Languages:

English


Showing results

110 of 3442

Chat now!